Cargando…

PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response

The ADP-ribosyltransferase, PARP1 enzymatically generates and applies the post-translational modification, ADP-Ribose (ADPR). PARP1 roles in genome maintenance are well described, but recent work highlights roles in many fundamental processes including cellular identity and energy homeostasis. Herei...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Arnold, Younis, Awais Z., Evans, Alexander, Creighton, Jade V., Coveny, Clare, Boocock, David J., Sale, Craig, Lavery, Gareth G., Coutts, Amanda S., Doig, Craig L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121420/
https://www.ncbi.nlm.nih.gov/pubmed/37087471
http://dx.doi.org/10.1038/s41420-023-01420-2
_version_ 1785029373852647424
author Tan, Arnold
Younis, Awais Z.
Evans, Alexander
Creighton, Jade V.
Coveny, Clare
Boocock, David J.
Sale, Craig
Lavery, Gareth G.
Coutts, Amanda S.
Doig, Craig L.
author_facet Tan, Arnold
Younis, Awais Z.
Evans, Alexander
Creighton, Jade V.
Coveny, Clare
Boocock, David J.
Sale, Craig
Lavery, Gareth G.
Coutts, Amanda S.
Doig, Craig L.
author_sort Tan, Arnold
collection PubMed
description The ADP-ribosyltransferase, PARP1 enzymatically generates and applies the post-translational modification, ADP-Ribose (ADPR). PARP1 roles in genome maintenance are well described, but recent work highlights roles in many fundamental processes including cellular identity and energy homeostasis. Herein, we show in both mouse and human skeletal muscle cells that PARP1-mediated PARylation is a regulator of the myogenic program and the muscle transcriptional response to steroid hormones. Chemical PARP1 modulation impacts the expression of major myocellular proteins, including troponins, key in dictating muscle contractile force. Whilst PARP1 in absence of DNA damage is often assumed to be basally inactive, we show PARylation to be acutely sensitive to extracellular glucose concentrations and the steroid hormone class, glucocorticoids which exert considerable authority over muscle tissue mass. Specifically, we find during myogenesis, a transient and significant rise in PAR. This early-stage differentiation event, if blocked with PARP1 inhibition, reduced the abundance of important muscle proteins in the fully differentiated myotubes. This suggests that PAR targets during early-stage differentiation are central to the proper development of the muscle contractile unit. We also show that reduced PARP1 in myoblasts impacts a variety of metabolic pathways in line with the recorded actions of glucocorticoids. Currently, as both regulators of myogenesis and muscle mass loss, glucocorticoids represent a clinical conundrum. Our work goes on to identify that PARP1 influences transcriptional activation by glucocorticoids of a subset of genes critical to human skeletal muscle pathology. These genes may therefore signify a regulatory battery of targets through which selective glucocorticoid modulation could be achieved. Collectively, our data provide clear links between PARP1-mediated PARylation and skeletal muscle homeostatic mechanisms crucial to tissue mass maintenance and endocrine response.
format Online
Article
Text
id pubmed-10121420
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-101214202023-04-24 PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response Tan, Arnold Younis, Awais Z. Evans, Alexander Creighton, Jade V. Coveny, Clare Boocock, David J. Sale, Craig Lavery, Gareth G. Coutts, Amanda S. Doig, Craig L. Cell Death Discov Article The ADP-ribosyltransferase, PARP1 enzymatically generates and applies the post-translational modification, ADP-Ribose (ADPR). PARP1 roles in genome maintenance are well described, but recent work highlights roles in many fundamental processes including cellular identity and energy homeostasis. Herein, we show in both mouse and human skeletal muscle cells that PARP1-mediated PARylation is a regulator of the myogenic program and the muscle transcriptional response to steroid hormones. Chemical PARP1 modulation impacts the expression of major myocellular proteins, including troponins, key in dictating muscle contractile force. Whilst PARP1 in absence of DNA damage is often assumed to be basally inactive, we show PARylation to be acutely sensitive to extracellular glucose concentrations and the steroid hormone class, glucocorticoids which exert considerable authority over muscle tissue mass. Specifically, we find during myogenesis, a transient and significant rise in PAR. This early-stage differentiation event, if blocked with PARP1 inhibition, reduced the abundance of important muscle proteins in the fully differentiated myotubes. This suggests that PAR targets during early-stage differentiation are central to the proper development of the muscle contractile unit. We also show that reduced PARP1 in myoblasts impacts a variety of metabolic pathways in line with the recorded actions of glucocorticoids. Currently, as both regulators of myogenesis and muscle mass loss, glucocorticoids represent a clinical conundrum. Our work goes on to identify that PARP1 influences transcriptional activation by glucocorticoids of a subset of genes critical to human skeletal muscle pathology. These genes may therefore signify a regulatory battery of targets through which selective glucocorticoid modulation could be achieved. Collectively, our data provide clear links between PARP1-mediated PARylation and skeletal muscle homeostatic mechanisms crucial to tissue mass maintenance and endocrine response. Nature Publishing Group UK 2023-04-22 /pmc/articles/PMC10121420/ /pubmed/37087471 http://dx.doi.org/10.1038/s41420-023-01420-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tan, Arnold
Younis, Awais Z.
Evans, Alexander
Creighton, Jade V.
Coveny, Clare
Boocock, David J.
Sale, Craig
Lavery, Gareth G.
Coutts, Amanda S.
Doig, Craig L.
PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
title PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
title_full PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
title_fullStr PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
title_full_unstemmed PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
title_short PARP1 mediated PARylation contributes to myogenic progression and glucocorticoid transcriptional response
title_sort parp1 mediated parylation contributes to myogenic progression and glucocorticoid transcriptional response
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121420/
https://www.ncbi.nlm.nih.gov/pubmed/37087471
http://dx.doi.org/10.1038/s41420-023-01420-2
work_keys_str_mv AT tanarnold parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT younisawaisz parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT evansalexander parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT creightonjadev parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT covenyclare parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT boocockdavidj parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT salecraig parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT laverygarethg parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT couttsamandas parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse
AT doigcraigl parp1mediatedparylationcontributestomyogenicprogressionandglucocorticoidtranscriptionalresponse